FDA Investigator Rebecca Co Bryan
Rebecca Co Bryan has conducted inspections on 131 sites in 1 countries as of 06 Nov 2006. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
131
Last Inspection Date:
06 Nov 2006
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Rebecca Co Bryan:
Adam C Hipko,
Adrian Rodriguez,
Akbar J Zaidi,
Alanna L Mussawwir Bias,
Alcee M Tavarez,
Althea A Williams,
Amanda J White,
Amy M Oliver,
Andrea A Branche,
Andrew J Lang,
Anh M Lac,
Anya Dlockett Evans,
Arie R Dyk,
Axel M Ambert,
Benjamin K Kingsley,
Betsy C Galliher,
Bing Lin,
Blondell W Johnson,
Bonnie L Menzel,
Brackens Harris,
Brandi E Williams,
Brandon K Barbee,
Brenda G Stewart Munoz,
Brent Sexton,
Brian Sanders,
Camille D Brown,
Carla A Norris,
Cassandra L Abellard,
Cathleen A Castellaw,
Chad J Whitwell,
Charles B Steinmiller,
Charles D Brown,
Christopher D Rush,
Christopher J Hurst,
Christopher K Gibbs,
Christopher L Jacobs,
Chunsheng Cai, PhD,
Coleen L Manoy,
Connie L Hannon Rabel,
Constance M Dobbins,
Cristina Alicea Matos,
Crystal S Harris,
Cynthia A Harris, MD, RN,
Dallas E Gilbreath Jr,
Dana M Lewis,
Daniel J Lahar,
Daniel S Fam,
Danielle Lyke,
Danny D Horner,
David M Beltran,
Decarlos A Gomez,
Denise Connelly,
Deniza Karacic,
Dr. Jason R Caballero,
Ed Gonzalez Vazquez,
Edmiston,
Edward D Edmiston,
Elisa M Fleming,
Ellen J Tave,
Elmina E Akwo,
Enspect User,
Ernest Serna, III,
Esteban Beltran,
Fernando C Martinez,
Florecia S Philogene,
Floyd D Herd,
Frans E Mercado,
Gery M Duparc,
Glasgow Glasgow,
Grant L Davis,
Gregory A Holt,
H Ljamilla Selby,
Hala L Selby,
Haley L Coleman,
Hung V Le,
Iris C Macinnes,
J Elkins,
Jacob W Reynolds,
Jamie M Bumpas,
Janet B Abt,
Janice M Hickok,
Jeffrey R Wooley,
Jennifer Cunningham,
Jennifer D Young,
Jennifer Hua,
Jennifer O Dowdy,
Joel D Martinez,
Johann M Fitch,
Jonaida Estevez Martinez,
Joshua L Gibbs,
Juan D Lopez,
Julia E Chervoni,
Karen C Daugherty,
Karlton T Watson,
Kathleen Chmura Shaffer,
Kayla R Deatherage,
Kelly D Sheppard,
Kenitra D Hewitt,
L Grant,
Lacedric V Harris,
Latorie S Jones,
Latrecia D Stubbs,
Laura B Kennedy,
Lauren E Skokan,
Lauren R Brady,
Leighton Kn Gai,
Linda Linh N Adams,
Linda Thai,
Lisa M Puttonen,
Lisa M Yoder,
Lisa R Jennings,
Lisa R Whitt,
Liza L Quiles,
Lloyd D Payne,
Lorie S Hannappel,
Lucas B Leake,
Marc R Dickens,
Margaret M Annes,
Margarito J Uribe,
Maria L Perales Uribe,
Mario Seminara,
Martha S Baldwin,
Micmarie Ramos Rodriguez,
Monica J Wilkins,
Monique Rac Lester,
Monique S Frazier,
Ninfa N Innocent,
Oluwasefunm Agbanigo,
Patrice S Hall,
Patrick D Stone, MS,
Paul Perdue (NMI), Jr,
Paulene M Wohlgemuth,
Pauline N Logan,
Philip M Steele, PhD,
Phillip D Waldron,
Pitman,
Rebecca C O'bryan,
Rendall E Barfoot,
Rene R Ramirez,
Rhonda L Dash,
Rian L Pope,
Robert M Tillman,
Robert T Lorenz,
Rodney L Tinzie,
Ronald Brent Sexton,
Ronda Rloyd Jones,
Roy Baby,
Samantha E Cleek,
Samuel A Hamblin,
Sandy J Ziegler,
Scott R Nichols, PhD,
Scott T Ballard,
Sean M Cheney,
Seri L Essary,
Shanna R Haden,
Shannon A Lowe,
Shawn E Larson,
Sherrie L Krolczyk,
Sina Shojaee,
Staci G Mcallister,
Stephen D Brown,
Stephen L Beekman,
Tamera H Hunt,
Tara A Gray,
Terrance L Thomas,
Terri E Gibson,
Theresa Kirkham (NMI),
Thomas Martinez,
Timothy B Webb,
Timothy J Herrman,
Toby Vern H Hill,
Tracy J Washington,
Travis S Bradley,
Travis S Brown,
Tricia S Martinez,
Trina K Vick,
Verlinda A Narcisse,
Vivian Garcia,
Yaw O Osei,
Young M Yoon
Rebecca Co Bryan's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2005 | FDA 483 | Estill Medical Technologies, Inc - Form 483, 2005-07-28 |
February, 2006 | FDA 483 | EEMSO Inc. - Form 483, 2006-02-23 |
October, 2003 | EIR | Cargill, Inc - Animal Nutrition Division - EIR, 2003-10-16 |
April, 2003 | EIR | CARGILL INCORPORATED - EIR, 2003-04-23 |
September, 2003 | EIR | Jorg J Pahl, MD - EIR, 2003-09-19 |
October, 2005 | FDA 483 | Neurotone Systems, Inc - Form 483, 2005-10-07 |
April, 2004 | EIR | Advanced Neuromodulation Systems, Inc- Sponsor - EIR, 2004-04-19 |
December, 2002 | EIR | Richard Adams - EIR, 2002-12-20 |
May, 2006 | FDA 483 | Neos Therapeutics, LP - Form 483, 2006-05-02 |
September, 2003 | FDA 483 | Jorg J Pahl, MD - Form 483, 2003-09-19 |
April, 2006 | FDA 483 | Mosaic Nutraceuticals Corp - Form 483, 2006-04-12 |
October, 2005 | FDA 483 | Seecor, Inc - Form 483, 2005-10-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more